Greenblatt, David J <br/><br/>
Evidence-based choice of ritonavir as index CYP3A inhibitor in drug-drug interaction studies.  [electronic resource] 

 -  Journal of clinical pharmacology  Feb 2016 
 - 152-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1552-4604 
<br/><br/><label>Standard No.: </label>10.1002/jcph.609  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cytochrome P-450 CYP3A<br/>Cytochrome P-450 CYP3A Inhibitors<br/>Drug Interactions<br/>HIV Protease Inhibitors--pharmacology<br/>Humans<br/>Ritonavir--pharmacology